Biomeme, Inc.

Check out the latest publication, featuring Biomeme's Portable RT-PCR System, by the King Abdullah International Medical Research Center ( KAIMRC). "Of the 192 samples tested using the Biomeme SARS-CoV-2 system, the results from 189 samples (98.4%) were in agreement with the reference standard-of-care RT-PCR testing for SARS-CoV-2. The portable system generated simultaneous results for nine samples in 80 mins with high positive and negative percent agreements of 99.0% and 97.8%, respectively." https://bit.ly/3rDXeC5

What to Know About SARS-CoV-2 Variants from a Leading Manufacturer of Portable PCR Testing Solutions https://bit.ly/3keU5WD

Hey Seth MacFarlane, you said our name right! We would like to extend a warm thank you to Seth MacFarlane and Variety for hosting Valentine's Day Concert this past weekend benefiting Motion Picture & Television Fund and BrightFocus. Biomeme was proud to be a sponsor of this event for such great causes. Everyone from camera operators and producers to hairstylists and makeup artists has been hit hard during the pandemic. They put their lives at risk every day to make sure the cameras continue to roll so that the rest of us continue to enjoy the programming we've become so accustomed to, especially during lockdown. Biomeme continues to do all that we can to ensure these dedicated individuals remain safe from COVID-19 and we appreciate their trust in us and our team.

BioIQ and Biomeme Announce Partnership for COVID Testing, Bringing the RT-PCR Laboratory and Gold-Standard Testing to the Worksite for Fast and Highly Sensitive Results

Update: Biomeme has confirmed, through in silico analysis of the genetic sequences, that our SARS-CoV-2 assay also detects the new variant reported by California (GH/452R.V1, B.1.429, CAL20.C). We continue to monitor variants as they emerge and will continue to update our information.

Biomeme’s SARS-CoV-2 Assay Detects New United Kingdom, South Africa, and Brazil Variants. We are continually monitoring for new information on developing variants.